Global Health Limited announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board also approved the fixation of a record date, August 14, 2026, for determining shareholders eligible for a proposed final dividend of ₹0.50 per equity share, subject to shareholder approval at the upcoming Annual General Meeting.
Global Health Announces Q1 FY27 Financial Results and Dividend Approval
Global Health Limited (GHL) has announced the outcomes of its Board of Directors meeting held on Thursday, July 30, 2026. The board inter alia approved the unaudited standalone and consolidated financial results for the First Quarter ended June 30, 2026. Certified copies of these results, along with the limited review reports from statutory auditors M/s Walker Chandiok & Co LLP, have been enclosed.
Dividend and AGM Details
In addition to the financial results, the board approved the notice for the 22nd Annual General Meeting (AGM), scheduled for Wednesday, September 16, 2026, at 12:00 Noon, to be conducted via Video Conferencing/Other Audio Video Means. Crucially, pursuant to Regulation 42 of the Listing Regulations, the company has fixed the record date for the payment of final dividend for the financial year 2025-26. The record date is set as Friday, August 14, 2026. The proposed final dividend is ₹0.50 per equity share, contingent upon approval by the shareholders at the ensuing AGM. This dividend is to be paid within 30 days from its declaration.
Key Personnel Appointment and Expansion Plans
The Board also approved the appointment of Mr. Pradeep Kumar Singh as ‘Chief Digital Officer’ and a Senior Management Personnel (SMP) of the Company, effective July 30, 2026. Further, the company approved a revised construction plan for its upcoming hospital in Guwahati, increasing the proposed bed capacity from 400 beds to 650 beds. Details regarding these approvals, as required under Regulation 30, are enclosed in Annexure-II and Annexure-III respectively.
Trading Window
The trading window for the company’s securities will reopen 48 hours after the declaration of these results to the stock exchanges.
The Board meeting commenced at 02:00 P.M. and concluded at 03:25 P.M.
Financial Highlights (Unaudited Standalone)
Quarter Ended June 30, 2026
- Revenue from operations: ₹10,787.23 million
- Profit before tax: ₹1,831.10 million
- Profit after tax: ₹1,373.07 million
- Comprehensive income: ₹1,325.55 million
Financial Highlights (Unaudited Consolidated)
Quarter Ended June 30, 2026
- Revenue from operations: ₹13,040.51 million
- Profit before tax: ₹2,132.63 million
- Profit after tax: ₹1,572.52 million
- Comprehensive income: ₹1,520.89 million
Source: BSE
